BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 18, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory actions for Feb. 2, 2021

Feb. 2, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, BMS, Cerecor, Chinook, Durect, Kintor, Mustang, Neurmedix, Paxmedica, Russian Direct Investment Fund, Sesen, SQZ, VBI Vaccines.
Read More

Other news to note for Feb. 2, 2021

Feb. 2, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagene, Adamas, Adverum, Aeterna, Aikido, Annovis, Ascentage, Bharat Biotech, Biovaxys, Can-Fite, Cevec, Circ, Coherus, Engrail, Evozyne, Exelixis, Genentech, Harbour Biomed, Ilias, Immunome, Junshi, Maia, Mati, Max, Moleculin, Neurocycle, Novelion, Ocugen, Ono, Oragenics, Paragon, Probiogen, Q, Regeneron, Ribon, Rznomics, Viewpoint Molecular, Virios, X-Chem, Zebiai, Zydus.
Read More

In the clinic for Feb. 2, 2021

Feb. 2, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abpro, Arch, Arena, Biomx, BMS, Bridgebio, Calcimedica, Cassava, Chemomab, Curis, Daiichi, Diurnal, Exonate, Gedea, Gemini, Immunovant, Janssen, Kira, Pharnext, Pinteon, RDIF, Secura, Selva, Tiziana, Travere, Verona.
Read More

Other news to note for Feb. 1, 2021

Feb. 2, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcus, Aicuris, Algernon, Akari, Biontech, Cognition, Curevac, Dynavax, Eversana, Gilead, Gritstone, Iterum, Kamada, Metrion, Noveome, Nyrada, Pfizer, Rentschler, Sonnet, Sosei, Sumitomo Dainippon, Titan, Valneva, Vir.
Read More
Digital imaging technology

NICE publishes guidelines for AI use in select imaging procedures

Feb. 1, 2021
By Nuala Moran
LONDON – The U.K. National Institute for Health and Care Excellence (NICE) has published new advice on how and when artificial intelligence (AI) could be applied to the interpretation of mammograms and chest computer tomography images, in a move that is intended to set the ground rules for the uptake of these technologies. In population breast screening, NICE looked at how five AI systems could be used to pick out mammography images that need further assessment, supporting qualified radiologists in their interpretation.
Read More

Other news to note for Feb. 1, 2021

Feb. 1, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alivecor, Althea UK and Ireland, Ambu, Ascensia, Avails Medical, Cadwell Industries, Cardiovascular Systems, Chansu Vascular Technologies, Circularity Healthcare, Earlysense, Fuse Medical, Hillrom, Innova Medical Group, Laborie Medical Technologies, Mayo Clinic, Orthovestments, Roche, Seegene, Senseonics, Setpoint Medical, Urotronic.
Read More

In the clinic for Feb. 1, 2021

Feb. 1, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ampio, Arcutis, Enb, Clover, Concert, Matinas, Merck, Novan, Sifi, Sorrento, Spark, Vaccitech, Vicore, Zosano.
Read More
Regulatory front

U.S. Senators: More protection needed for genomic data

Feb. 1, 2021
By Mari Serebrov
The latest global regulatory news, changes and updates affecting biopharma, including: Veterans’ genomic data put at risk; DNA sequencing claims struck down; More BREXIT guidance.
Read More
Woman stands in front of COVID-19 screening system

Health Canada approves Monitio’s COVID-19 screening system

Jan. 29, 2021
By David Godkin
TORONTO – Startup CEOs may sometimes be forgiven a little exuberance on learning their technology has received the high sign from regulatory officials. So it was when the head of Monitio Intelligence Inc. Ben Su sifted through his email at his office in Coburg Ontario and saw the Health Canada logo at the top of the letter. “I was actually jumping up and down when I received that authorization letter. I was very excited,” Su said. Since then Su has been overseeing installation of an automated COVID-19 screening system.
Read More

Regulatory front for Jan. 29, 2021

Jan. 29, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA reissues policy for coagulation systems; FDA announces recall of Penumbra’s Jet 7; Stericycle to buy buses as part of settlement; Athena agrees to $18M fine; WHO refreshes essential diagnostics list; TGA pulls two pandemic-driven exemptions.
Read More
Previous 1 2 … 292 293 294 295 296 297 298 299 300 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2026.
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • Illustration of human brain and dna

    Voyager’s gene therapy reduces tau levels in AD models

    BioWorld Science
    At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing